Immunosuppressive activity of an isoxazolo[5,4-e]triazepine - Compound RM33. I. Effects on the humoral and cellular immune response in mice

Pharmacological Reports

Volumn 57, Issue 2, 2005, Pages 195-202

  Ryng, Stanisław ^a   Zimecki, Michał ^b   Maczynski, Marcin ^a   Chodaczek, Grzegorz ^b   Kocieba, Maja ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Cellular immune response; Cytokines; Humoral; Immunosuppression; Isoxazolotriazepines; Mice

Indexed keywords

CYCLOSPORIN A; CYTOKINE; FREUND ADJUVANT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 6; ISOXAZOLE DERIVATIVE; ISOXAZOLO[5,4 E]TRIAZEPINE DERIVATIVE; LEVAMISOLE; LIPOPOLYSACCHARIDE; OVALBUMIN; RM 33; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; EDEMA; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FOOT PAD; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MALE; MOUSE; NONHUMAN; SHEEP ERYTHROCYTE; SIGNAL TRANSDUCTION; SPLEEN CELL; STRUCTURE ANALYSIS;

EID: 20344396355     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bartlett RR: Immunopharmacological profile of HWA 486, a novel isoxazole derivative - II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A. Int J Immunopharmacol, 1986, 8, 199-204.
2. Beam CF, Park CA, Heinel ND, Fives WP: The synthesis of 2-carbomethoxy-2-carbomethoxymethyl-2, 3-dihydro-4(1H)quinazolinones. J Heterocycl Chem, 1977, 14, 703-704.
3. Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, Grunig G et al: Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest, 1995, 96, 2339-2347.
4. Cox JC, Coulter AR: Adjuvants - a classification and review of their modes of action. Vaccine, 1997, 15, 248-256
5. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI 164 clone 13, measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods, 1986, 95, 99-105.
6. Esseffar M, Jalal R, El Messaoudi M, El Mouhtadi M: AM1 theoretical study on the mechanism of 1,3-dipolar cycloaddition reaction of 1,2,4-triazepine and formonitrile oxide. J Mol Struct (THEOCHEM), 1998, 433, 301-309.
7. Lagrange PH, Mackaness GB, Miller TE, Pardon P: Influence of dose and route of antigen injection on the immunological function of T cells. J Exp Med, 1974, 139, 528-542.
8. Lang R, Wagner H, Heeg K: Differential effects of the immunosuppressive agents cyclosporine and leflunomide in vivo. Leflunomide blocks clonal T cell expension yet allows production of lymphokines and manifestation of T-cell-mediated shock. Transplantation, 1995, 59, 382-289.
9. Machoń Z, Ryng S: Synthesis and biological properties of 5-benzoylamino-3-methyl-4-isoxazolocarboxylic acid derivatives. Arch Immunol Ther Exp, 1981, 29, 813-821.
10. Machoń Z, Ryng S: Synthesis and pharmacological properties of derivatives of isoxazolo [5,4-d]-6,7-dihydropyrimidines. Pol J Pharmacol Pharm, 1988, 40, 209-216.
11. Mishell RI, Dutton RW: Immunization of dissociated spleen cell cultures from normal mice. J Exp Med, 1967, 126, 423-442.
12. Mohsen A, Omar ME, Ashour FA, Bourdais J: The cyclodesulfurization of thio-compounds. Part XVII. Synthesis of some novel 2-substituted amino-3,4-dihydro-5H-1,3,4-benzotriazepin-5-ones by cyclodesulfurization of thiosemicarbazides with dicyclohexylcarbodiimide (DCCD). J Heterocycl Chem, 1979, 16, 1435-1438.
13. Ostraat O, Qi ZQ, Tufveson G, Hedlund G, Ekberg H: The effects of leflunomide and cyclosporin A on rejection of cardiac allografts in rat. Scand J Immunol, 1998, 47, 236-242.
14. Remick DG: Lung and gut injury induced by tumor necrosis factor. Res Immunol, 1993, 144, 326-331.
15. Rezessy B, Zubovics Z, Kovacs J, Toth G: Synthesis and structure elucidation of new thiazolotriazepines. Tetrahedron, 1999, 55, 5909-5922.
16. Ryng S, Głowiak T: The isoxazole heterocyclic system: synthesis of a new model structure in immunosuppressing agents. J Chem Crystallogr, 1998, 28, 373-378.
17. Ryng S, Machoń Z, Wieczorek Z, Zimecki M, Głowiak T: Synthesis and structure elucidation of 5-amino-methinimino-3-methyl-4-isoxazolecarboxylic acid phenylamides and their immunological activity. Arch Pharm, 1997, 330, 319-326.
18. Ryng S, Malinka W, Duś D: Synthesis and cytostatic properties of 5-substituted derivatives of 3-methylisoxazolo[5,4-d]1,2,3-triazine-4-ones and 3-methyl-5-triazene 4-isoxazolecarboxylic acid ethyl esters. Farmaco, 1997, 52, 105-108.
19. Ryng S, Sonnenberg Z, Zimecki M: RM11, a new izoxasole derivative, is a potent stimulator of the humoral and cellular immune responses in mice. Arch Immunol Ther Exp, 2000, 48, 127-131.
20. Sladowska H, Bodetko M, Sieklucka-Dziuba M, Rajtar G, Ziolkowska D, Kleinrok Z: Transformation of some pyrido[2,3-d]pyrimidine derivatives into other di- and triheterocyclic systems. Farmaco, 1997, 52, 657-662.
21. Srivastava S, Bajpai KL, Batra S, Bhaduri A, Maikhuri JP, Gupta G, Dhar JD: In search of new chemical entities with spermicidal and anti-HIV activities. Bioorg Med Chem, 1999, 7, 2607-2613.
22. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JH: Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood, 1994, 83, 113-118
23. Van Snick J, Cayphas S, Vink A, Uyttenhove C, Coulie PG, Rubira MR, Simpson RJ: Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA, 1986, 83, 9679-9683.
24. Verardo G, Toniutti N, Gorassini A, Giumanini AG: New heterocycles from the reaction between some natural α-amino acid hydrazides and formaldehyde. Eur J Org Chem, 1999, 11, 2943-2948.
25. Welborn MB 3rd, Van Zee K, Edwards PD, Pruitt JH, Kaibara A, Vauthey JN, Rogy M et al.: A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon. J Exp Med, 1996, 184; 165-171.
26. Yamamoto Y, Shindo M, Nakamura T. PCT Int. Appl. WO 9747622, 1998 [Chem. Abstr. 1998, 128, 75427].